Annual Update in Medical Hepatology
The primary purpose of the 5th annual 2024 UPMC Annual Update in Medical Hepatology is to bring physicians, researchers, and hepatology associates together to advance our understanding of the origin and progression of liver diseases and to provide optimal treatments to patients as soon as possible. This February 3, 2024 course is led by academic physicians who are committed to broad collaboration to support patients who desperately need answers.
We are delighted to welcome Samer Gawrieh, MD from the University of Indiana, Gideon Hirschfield, MB BChir, PhD, MRCP from the University of Toronto and Tinsay Woreta, MD, MPH from Johns Hopkins Medicine as our 2024 guest speakers. We also look forward to lively debates and interactions from all course attendees throughout the day, particularly throughout the day’s case discussions and during the lunch breakout meetings.
We also invite you to meet new UPMC Center for Liver Diseases faculty members Scott Biggins, MD and Kiran Bambha, MD, who will join UPMC in January 2024. Dr. Biggins will serve as the UPMC’s Chief of Hepatology.
This 2024 UPMC Annual Update in Medical Heaptology conference is indebted to its industry partners. Please Visit our Exhibitors in the Gold Room (same floor as plenary sessions) throughout the conference.
Thank you for attending.
In good health,
Jaideep Behari, MD, PhD
Associate Professor of Medicine
Director, FLOW (Fatty Liver, Obesity & Wellness) Clinic
Course Co-Director, 2022 UPMC Annual Update in Medical Hepatology
Shahid Malik, MD
Clinical Associate Professor of Medicine
Program Director, Advanced Fellowship in Transplant Hepatology
Course Co-Director, 2022 UPMC Annual Update in Medical Hepatology
Amy Schmotzer, RN, BSN
Clinical Research Coordinator
Course Planning Committee, 2022 UPMC Annual Update in Medical Hepatology
Division of Gastroenterology, Hepatology and Nutrition
UPMC Center for Liver Diseases
University of Pittsburgh | UPMC
Target Audience
This course is designed for hepatologists, gastroenterologists, surgeons, oncologists, radiologists, basic and clinical researchers, and general physicians. Physicians and scientists interested in hepatology clinical service, clinical research, and career development are encouraged to attend. Advanced practice providers, clinical and research nurses, and related health care professionals interested in hepatology medicine are also invited to attend.
Learning Objectives
- Partner with other regional academic liver practitioners to educate the regional and national medical communities about liver disease advancements.
- Identify advancements in autoimmune liver diseases, such as Primary Sclerosing Cholangitis and the involvement of the gut microbiome, as well as explore cirrhosis and its complications.
- Examine treatment strategies and lifestyle modifications for steatotic and viral liver diseases.
- Address barriers to liver transplantation and living donor liver transplantation, leading to enhanced patient care.
- Foster the development of multidisciplinary, fluid and interactive models to treat liver diseases.
Additional Information
Attachment | Size |
---|---|
Handout 2-3-24 (Final).pdf | 465.14 KB |
AGENDA (In-person)
AGENDA (Virtual)
Session 1.1: Case #1 Introduction - Stela Celaj, MD, PhD
Session 1.2: Update on Primary Sclerosing Cholangitis - Gideon Hirschfield, MA, MB Chir, PhD, FRCP
Session 1.3: Update on PBC and Overlap Syndromes - Naudia L. Jonassaint, MD, MHS, MBA
Session 2.1: Case #2 Introduction - Phoebe Lin, MD
Session 2.4: Management Dilemmas in Hepatitis B and C Infections - Kapil Chopra, MD
Breakout #2: Lifestyle Modification for the Management of Liver Disease: Case-based Panel Discussion
Session 3.1: Case #3 Introduction - Linda Wang, MD
Session 3.2: Management of the Difficult Variceal Hemorrhage - Shahid M. Malik, MD
Session 3.3 : Advances in the Management of Hepatorenal Syndrome - Alex Myint, MD
Session 3.4: Managing Quality of Life in Patients with Advanced Cirrhosis - Shari S. Rogal, MD, MPH
Session 4.1: Case #4 Introduction - Pranav Penninti, DO
Session 4.2: Advances in Deceased Donor Liver Transplantation Scott Biggins, MD, MAS
Session 4.3: Innovations in Live Donor Liver Transplantation Kiran Bambha, MD, MSc
Course Planning Committee and Internal Course Faculty:
Internal Course Faculty serve with the UPMC Center for Liver Diseases and the University of Pittsburgh Division of Gastroenterology, Hepatology and Nutrition, unless noted otherwise.
Jaideep Behari, MD, PhD
Associate Professor of Medicine
Director, FLOW (Fatty Liver, Obesity and Wellness) Clinic
Course Co-Director, 2024 UPMC Annual Update in Medical Hepatology
Shahid Malik, MD
Clinical Associate Professor of Medicine
Program Director, Advanced Fellowship in Transplant Hepatology
Course Co-Director, 2024 UPMC Annual Update in Medical Hepatology
Amy Roundtree Schmotzer, RN, BSN
Lead Clinical Research Coordinator
Course Planning Committee, 2024 UPMC Annual Update in Medical Hepatology
Guest Course Faculty:
Samer Gawrieh, MD
Professor of Clinical Medicine
Director, Hepatology Research Fellowship Program
Division of Gastroenterology and Hepatology
Indiana University School of Medicine
Indianapolis, IN
Gideon M. Hirschfield, MB BChir,PhD, MRCP
Lily and Terry Horner Chair in Autoimmune Liver Disease Research
Staff Hepatologist
Toronto Centre for Liver Disease
University of Toronto Medicine
Toronto, Ontario, Canada
Tinsay A. Woreta, MD, MPH
Assistant Professor of Medicine
Program Director, Gastroenterology and Transplant Hepatology Fellowships
Johns Hopkins Medicine
Baltimore, MD
Internal Course Faculty:
Kiran Bambha, MD
Professor of Medicine
Scott Biggins, MD
Professor of Medicine
Chief of Hepatology, UPMC Center for Liver Diseases
Kevin Abercrombie, CRNP
Advanced Practice Provider
Stela Celaj, MD, PhD
Advanced Fellow in Transplant Hepatology
Kapil B. Chopra, MD
Professor of Medicine
Vice Chair of Medicine, UPMC Mercy
Naudia L. Jonassaint, MD, MHS, MBA
Associate Professor of Medicine
Interim Chief, Division of Gastroenterology, Hepatology and Nutrition
Associate Dean for Clinical Affairs, School of Medicine
Phoebe Lin, MD
Gastroenterology and Hepatology Fellow, Year II
Joy McGough, RN
Nurse
Marlies Meisel, PhD
Assistant Professor of Immunology
Alex Myint, MD
Clinical Assistant Professor of Medicine
Alan G. Noll, MD
Chief Gastroenterology and Hepatology Fellow, Year III
Sara Parr, RD
Dietitian, FLOW Clinic (Fatty Liver, Obesity & Wellness)
Pranav Penninti, DO
Advanced Fellow in Transplant Hepatology
Kristen Radage, LCSW
Social Worker
Shari S. Rogal, MD, MPH
Associate Professor of Medicine and Surgery
Co-director, CTSI IMPACT and Implementation Lab Cores
Core Investigator, Center for Health Equity Research and
Promotion, VA Pittsburgh Healthcare System
Obaid S. Shaikh, MD
Professor of Medicine
Director, Transplantation Medicine, VA Pittsburgh
Healthcare System
Linda Wang, MD
Gastroenterology & Hepatology Fellow, Year II
COURSE FACULTY DISCLOSURE:
All individuals in a position to control the content of this education activity have disclosed all financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All of the relevant financial relationships for the individuals listed below have been mitigated:
▪ Jaideep Behari, MD, PhD receives grant/research support from Pfizer, Gilead, Endra, and AstraZeneca. He also participates in institutional research contracts with Pfizer, Intercept, Galectin, Exact Sciences, Genentech, Inventiva, Enanta, Galmed, Rhythm, and Celgene.
▪ Samer Gawrieh, MD receives grant/research support from Zydus, Viking, and Sonicincytes. He is also a consultant for Pfizer and Transmedics.
▪ Gideon Hirschfield, MB BChir, PhD, MRCP is a consultant with Intercept, Advanz, Ipsen, Cymabay, GSK, Pliant, Mirum, Kowa, and Escient.
No other members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing (CNE)
The maximum number of hours awarded for this Continuing Nursing Education activity is 6.25 contact hours.
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 6.25 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 6.25 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 6.25 Attendance
We gratefully acknowledge conference support from the following industry partners:
EDUCATIONAL GRANTS
Intercept Pharmaceuticals, Inc.
ST Shared Services LLC, a Mallinckrodt Company
Salix Pharmaceuticals, A Division of Bausch Health US, LLC
PREMIER EXHIBIT SPONSORSHIPS
Gilead Sciences
Intercept Pharmaceuticals, Inc.
Salix Pharmaceuticals
EXHIBIT SPONSORSHIPS
AstraZeneca
Eisai
Exact Sciences
Ipsen
Madrigal Pharmaceuticals
Mallinckrodt Pharmaceuticals
Takeda Pharmaceuticals, U.S.A., Inc.
US Digestive Health
Price
In-person or Virtual Attendance | Early through 1/30/24 | Late or Onsite as of 1/30/24 |
Industry Personnel (non-exhibitor) | 100 | 150 |
Faculty & Physicians | 50 | 75 |
Advanced Practice Providers, Nurses, & Trainees | 0 | 25 |
Participation by all individuals is encouraged. Advance notification of any special needs will help us provide better service. Please notify us of your needs at least two weeks in advance of the program by emailing joj2@pitt.edu.